Clinical_JJ review_NN :_: Intensive_JJ care_NN follow-up_NN --_: what_WP has_VBZ it_PP told_VBD us_PP ?_SENT Abstract_NN |_SYM The_DT majority_NN of_IN intensive_JJ care_NN practitioners_NNS ,_, until_IN comparatively_RB recently_RB ,_, was_VBD content_JJ to_TO discharge_VB surviving_VBG patients_NNS to_TO the_DT care_NN of_IN referring_VBG primary_JJ specialty_NN colleagues_NNS who_WP would_MD undertake_VB subsequent_JJ inpatient_NN and_CC outpatient_NN care_NN ._SENT With_IN the_DT exception_NN of_IN mortality_NN statistics_NNS from_IN clinical_JJ studies_NNS ,_, the_DT practitioners_NNS were_VBD thus_RB denied_VBN the_DT opportunity_NN of_IN understanding_VBG the_DT full_JJ impact_NN of_IN critical_JJ illness_NN on_IN a_DT patient_NN and_CC their_PP$ family_NN ._SENT The_DT concept_NN of_IN the_DT intensive_JJ care_NN follow-up_NN clinic_NN has_VBZ developed_VBN more_RBR recently_RB ,_, and_CC is_VBZ run_VBN commonly_RB on_IN multidisciplinary_JJ lines_NNS ._SENT These_DT clinics_NNS serve_VBP a_DT number_NN of_IN purposes_NNS ,_, but_CC importantly_RB have_VBP drawn_VBN attention_NN to_TO broader_JJR patient-centred_JJ outcomes_NNS after_IN intensive_JJ care_NN ._SENT Investigators_NNS are_VBP just_RB beginning_VBG to_TO identify_VB ,_, and_CC in_IN some_DT cases_NNS quantify_VBP ,_, the_DT postdischarge_JJ burden_NN on_IN patient_NN and_CC family_NN ;_: additional_JJ useful_JJ data_NNS have_VBP also_RB come_VBN from_IN follow-up_NN of_IN specific_JJ disease_NN states_NNS ._SENT The_DT purpose_NN of_IN the_DT present_JJ review_NN is_VBZ to_TO highlight_VB some_DT of_IN the_DT important_JJ issues_NNS that_DT impact_NN on_IN recovery_NN from_IN critical_JJ illness_NN towards_IN an_DT acceptable_JJ quality_NN of_IN postdischarge_NN life_NN ._SENT We_PP have_VBP concentrated_VBN on_IN the_DT adult_JJ literature_NN ,_, and_CC specifically_RB on_IN studies_NNS that_WDT inform_VB us_PP about_IN the_DT more_JJR general_JJ effects_NNS of_IN critical_JJ illness_NN ._SENT Head_NN and_CC spinal_JJ injury_NN are_VBP thus_RB largely_RB ignored_VBN ,_, as_IN the_DT effects_NNS of_IN the_DT primary_JJ injury_NN overwhelm_VB the_DT effects_VBZ of_IN '_'' general_NN '_POS critical_JJ illness_NN ._SENT critical_JJ illness_NN ,_, follow-up_NN studies_NNS ,_, neuropsychology_NN ,_, outcome_NN assessment_NN (_( healthcare_NN )_) ,_, quality_NN of_IN life_NN ,_, up_RB studies_NNS ,_, neuropsychology_NN ,_, outcome_NN assessment_NN (_( healthcare_NN )_) ,_, quality_NN of_IN life_NN ,_, The_DT impact_NN of_IN critical_JJ illness_NN on_IN life_NN expectancy_NN :_: The_DT attrition_NN imposed_VBN on_IN health_NN reserve_NN by_IN a_DT critical_JJ illness_NN is_VBZ highlighted_VBN by_IN a_DT number_NN of_IN long-term_JJ follow-up_NN studies_NNS ._SENT The_DT 5-year_JJ mortality_NN rate_NN for_IN intensive_JJ care_NN unit_NN (_( ICU_NP )_) survivors_NNS is_VBZ reported_VBN to_TO be_VB more_JJR than_IN threefold_RB higher_JJR than_IN for_IN the_DT general_JJ population_NN ._SENT Actuarial_JJ survival_NN curves_NNS for_IN ICU_NP survivors_NNS only_RB run_VBP parallel_RB to_TO the_DT general_JJ population_NN around_IN 2_CD --_: 3_CD years_NNS after_IN hospital_NN discharge_NN ._SENT However_RB ,_, marked_JJ differences_NNS occur_VBP depending_VBG on_IN the_DT diagnostic_JJ category_NN ._SENT Medical_JJ patients_NNS requiring_VBG a_DT period_NN in_IN ICU_NP have_VBP an_DT estimated_JJ hospital_NN mortality_NN of_IN 23.2_CD %_NN compared_VBN with_IN 14.1_CD %_NN for_IN surgical_JJ patients_NNS ._SENT The_DT difference_NN between_IN medical_JJ patient_JJ survival_NN and_CC surgical_JJ patient_JJ survival_NN appears_VBZ to_TO be_VB sustained_VBN beyond_IN the_DT ICU_NP period_NN ._SENT In_IN one_CD investigation_NN ,_, the_DT median_JJ survival_NN period_NN for_IN medical_JJ patients_NNS was_VBD reported_VBN as_IN 40_CD days_NNS post-ICU_NN admission_NN compared_VBN with_IN more_JJR than_IN 900_CD days_NNS for_IN other_JJ patients_NNS ._SENT Patients_NNS often_RB find_VBP themselves_PP unable_JJ to_TO accomplish_VB even_RB simple_JJ physical_JJ tasks_NNS without_IN exhaustion_NN after_IN a_DT period_NN of_IN critical_JJ illness_NN ._SENT A_DT variety_NN of_IN aspects_NNS of_IN physical_JJ status_NN may_MD contribute_VB to_TO impaired_JJ physical_JJ functioning_NN ,_, and_CC this_DT may_MD have_VB an_DT important_JJ impact_NN on_IN quality_NN of_IN life_NN ._SENT Table_NP 1_CD |_SYM Common_JJ physical_JJ problems_NNS following_VBG a_DT period_NN in_IN the_DT intensive_JJ care_NN unit_NN Nutrition_NP |_SYM One_CD invariable_JJ consequence_NN of_IN a_DT period_NN of_IN critical_JJ illness_NN is_VBZ weight_NN loss_NN ._SENT Losses_NNS of_IN 2_CD %_NN lean_JJ body_NN mass_NN per_IN day_NN have_VBP been_VBN reported_VBN ,_, which_WDT can_MD leave_VB the_DT patient_NN with_IN a_DT formidable_JJ energy_NN and_CC protein_NN deficit_NN ._SENT Keys_NP et_FW al._FW demonstrated_VBD that_IN even_RB healthy_JJ volunteers_NNS required_VBD longer_JJR than_IN 1_CD year_NN to_TO recover_VB lean_JJ body_NN mass_NN following_VBG a_DT period_NN of_IN prolonged_JJ starvation_NN ._SENT Weakness_NN ,_, depression_NN ,_, breathlessness_NN and_CC altered_JJ taste_NN perception_NN are_VBP likely_JJ to_TO reduce_VB a_DT patients_NNS '_POS appetite_NN and_CC therefore_RB to_TO slow_VB recovery_NN of_IN body_NN mass_NN ._SENT The_DT inter-relationships_NNS between_IN tissue_NN loss_NN and_CC physiological_JJ function_NN are_VBP complex_JJ and_CC depend_VB on_IN the_DT setting_NN within_IN which_WDT malnutrition_NN arises_VBZ ._SENT There_EX are_VBP few_JJ published_VBN data_NNS regarding_VBG long-term_JJ nutritional_JJ follow-up_NN of_IN general_JJ ICU_NP patients_NNS ._SENT Glutamine_NN supplementation_NN during_IN the_DT acute_JJ phase_NN of_IN illness_NN appears_VBZ to_TO have_VB a_DT beneficial_JJ effect_NN that_WDT is_VBZ measurable_JJ at_IN 6_CD months_NNS ._SENT In_IN addition_NN ,_, a_DT number_NN of_IN patients_NNS suffer_VBP mechanical_JJ difficulties_NNS in_IN swallowing_VBG specifically_RB related_VBN to_TO healing_VBG tra-cheostomy_NN sites_NNS ._SENT Neuropathy_NN |_SYM Critical_JJ illness_NN neuropathy_NN is_VBZ a_DT well-recognized_JJ axonal_JJ neuropathy_NN occurring_VBG in_IN ICU_NP patients_NNS ._SENT Although_IN recovery_NN can_MD be_VB anticipated_VBN within_IN a_DT few_JJ months_NNS in_IN milder_JJR cases_NNS ,_, more_JJR severe_JJ forms_NNS can_MD have_VB devastating_JJ consequences_NNS ._SENT In_IN a_DT recent_JJ 2-year_JJ follow-up_NN of_IN 19_CD patients_NNS suffering_VBG severe_JJ critical_JJ illness_NN neuropathy_NN (_( characterized_VBN by_IN quadriplegia_NN or_CC quadraparesis_NN )_) associated_VBN with_IN sepsis_NN and_CC multiple_JJ organ_NN failure_NN ,_, two_CD patients_NNS died_VBN within_IN 2_CD months_NNS ,_, 11_CD patients_NNS recovered_VBD completely_RB ,_, four_CD patients_NNS remained_VBD quadriplegic_JJ ,_, and_CC two_CD patients_NNS remained_VBD quadraparetic_JJ ._SENT In_IN that_DT study_NN ,_, three_CD parameters_NNS correlated_VBN with_IN poor_JJ recovery_NN :_: longer_JJR length_NN of_IN stay_NN in_IN the_DT ICU_NP ,_, longer_JJR duration_NN of_IN sepsis_NN ,_, and_CC greater_JJR weight_NN loss_NN ._SENT The_DT cause_NN of_IN critical_JJ illness_NN neuropathy_NN remains_VBZ obscure_JJ ._SENT Numerous_JJ factors_NNS have_VBP been_VBN implicated_VBN but_CC ,_, as_IN yet_RB ,_, insufficient_JJ evidence_NN is_VBZ available_JJ to_TO attribute_VB cause_NN ,_, and_CC no_DT information_NN is_VBZ available_JJ regarding_VBG its_PP$ prevention_NN or_CC treatment_NN ._SENT Respiratory_JJ consequences_NNS |_SYM Breathlessness_NN is_VBZ a_DT common_JJ symptom_NN reported_VBN by_IN ICU_NP survivors_NNS ._SENT The_DT possible_JJ causes_NNS of_IN breathlessness_NN include_VBP muscle_NN weakness_NN ,_, neuropathy_NN ,_, pulmonary_JJ fibrosis_NN ,_, progression_NN of_IN premorbid_JJ respiratory_JJ and_CC cardiac_JJ disease_NN ,_, and_CC also_RB psychological_JJ factors_NNS ._SENT One_CD of_IN the_DT best-characterized_JJ ICU_NP diseases_NNS is_VBZ acute_JJ lung_NN injury_NN and_CC its_PP$ severe_JJ manifestation_NN ,_, the_DT acute_JJ respiratory_JJ distress_NN syndrome_NN (_( ARDS_NN )_) ._SENT Follow-up_NN studies_NNS have_VBP included_VBN physiology_NN ,_, radiology_NN ,_, quality_NN of_IN life_NN ,_, and_CC psychological_JJ consequences_NNS ._SENT Davidson_NP et_FW al._FW suggested_VBD that_IN ARDS_NP did_VBD not_RB increase_VB a_DT patient_NN 's_POS risk_NN of_IN death_NN beyond_IN discharge_NN from_IN hospital_NN ;_: the_DT long-term_JJ mortality_NN of_IN ARDS_JJ patients_NNS correlated_VBN with_IN age_NN ,_, underlying_VBG risk_NN factors_NNS ,_, and_CC comorbidity_NN ._SENT In_IN another_DT study_NN ,_, Davidson_NP et_FW al._FW used_VBN the_DT Medical_NP Outcomes_NP Study_NP Short_NP Form_NP (_( SF-36_NP )_) instrument_NN (_( a_DT generic_JJ quality-of-life_NN instrument_NN )_) and_CC the_DT St_NP George_NP 's_POS Respiratory_NP Questionnaires_NP (_( a_DT pulmonary-specific_JJ tool_NN )_) ._SENT They_PP assessed_VBD 73_CD ARDS_NN patients_NNS matched_VBN with_IN control_NN patients_NN having_VBG equal_JJ severity_NN of_IN disease_NN or_CC injury_NN ._SENT Davidson_NP et_FW al._FW concluded_VBD that_IN ,_, 2_CD years_NNS after_IN ICU_NP admission_NN ,_, ARDS_JJ survivors_NNS had_VBD clinically_RB significant_JJ reductions_NNS in_IN health-related_JJ quality_NN of_IN life_NN (_( HRQL_NP )_) that_WDT appeared_VBD to_TO be_VB caused_VBN exclusively_RB by_IN ARDS_NP and_CC its_PP$ sequelae_NNS ._SENT The_DT reductions_NNS were_VBD primarily_RB noted_VBN in_IN physical_JJ functioning_NN and_CC pulmonary_JJ disease-specific_JJ domains_NNS ._SENT Continuing_VBG respiratory_JJ dysfunction_NN thus_RB appears_VBZ to_TO be_VB associated_VBN with_IN a_DT broad_JJ impact_NN on_IN well-being_NN ,_, and_CC this_DT observation_NN is_VBZ unlikely_JJ to_TO be_VB specific_JJ to_TO ARDS_NN ._SENT Most_RBS ARDS_JJ survivors_NNS have_VBP abnormal_JJ pulmonary_JJ function_NN tests_NNS in_IN the_DT first_JJ 3_CD months_NNS of_IN recovery_NN ;_: this_DT reaches_VBZ a_DT plateau_NN over_IN the_DT following_VBG 3_CD --_: 9_CD months_NNS ._SENT Pulmonary_JJ function_NN tests_NNS following_VBG ARDS_NNS generally_RB demonstrate_VBP a_DT restrictive_JJ ven-tilatory_JJ defect_NN and_CC some_DT impairment_NN of_IN diffusion_NN capacity_NN ._SENT Alteration_NN of_IN lung_NN parenchymal_JJ compliance_NN has_VBZ been_VBN documented_VBN using_VBG whole_JJ body_NN plethysmography_NN and_CC measurement_NN of_IN transpulmonary_JJ pressure_NN ._SENT However_RB ,_, the_DT number_NN of_IN patients_NNS followed_VBN up_RP in_IN this_DT way_NN is_VBZ small_JJ and_CC the_DT significance_NN of_IN the_DT residual_JJ restrictive_JJ deficit_NN remains_VBZ to_TO be_VB clarified_VBN ._SENT Reduction_NN in_IN diffusion_NN capacity_NN may_MD be_VB more_RBR significant_JJ in_IN explaining_VBG reduced_VBN exercise_NN tolerance_NN in_IN these_DT individuals_NNS ,_, some_DT of_IN whom_WP desaturate_NN during_IN exertion_NN ._SENT Persistent_JJ radiographic_JJ changes_NNS in_IN survivors_NNS of_IN ARDS_NNS have_VBP been_VBN reported_VBN ._SENT Desai_NP et_FW al._FW examined_VBD computerized_JJ tomography_NN scans_NNS of_IN 27_CD survivors_NNS of_IN ARDS_NN ._SENT Follow-up_NN scans_NNS were_VBD performed_VBN 110_CD --_: 267_CD days_NNS (_( mean_VB +-_JJ standard_JJ deviation_NN ,_, 196.2_CD +-_NN 41.3_CD days_NNS )_) after_IN the_DT initial_JJ scan_NN performed_VBN during_IN ICU_NP admission_NN ._SENT The_DT most_RBS frequent_JJ persistent_JJ abnormality_NN ,_, in_IN 23_CD patients_NNS (_( 85_CD %_NN )_) ,_, was_VBD a_DT course_NN reticular_JJ pattern_NN with_IN an_DT anterior_JJ distribution_NN ._SENT The_DT extent_NN of_IN this_DT fibrotic_JJ appearance_NN was_VBD up_RB to_TO 31_CD %_NN of_IN the_DT lung_NN field_NN ._SENT A_DT ground_NN glass_NN appearance_NN ,_, which_WDT was_VBD taken_VBN to_TO indicate_VB either_DT oedema_NN or_CC fine_JJ fibrosis_NN below_IN the_DT resolution_NN of_IN the_DT scanner_NN ,_, was_VBD observed_VBN in_IN 17_CD survivors_NNS ;_: the_DT extent_NN ranging_VBG up_RP to_TO 56_CD %_NN ._SENT The_DT variation_NN in_IN extent_NN of_IN these_DT changes_NNS may_MD partly_RB explain_VB the_DT variation_NN in_IN pulmonary_JJ function_NN ._SENT The_DT importance_NN of_IN these_DT radiological_JJ changes_NNS to_TO function_VB remains_NNS unclear_JJ ._SENT Cardiac_JJ consequences_NNS |_SYM Although_IN the_DT cardiovascular_JJ system_NN often_RB requires_VBZ support_NN with_IN inotropes_NNS and_CC vasopressors_NNS ,_, it_PP is_VBZ assumed_VBN that_IN there_EX are_VBP no_DT long-term_JJ cardiac_JJ sequelae_NNS in_IN the_DT absence_NN of_IN infarction_NN ._SENT Using_VBG a_DT canine_JJ model_NN of_IN peritoneal_JJ sepsis_NN ,_, Cunnion_NP and_CC Parrillo_NP found_VBD that_IN cardiac_JJ function_NN returned_VBN to_TO normal_JJ within_IN a_DT few_JJ days_NNS of_IN recovery_NN from_IN a_DT septic_JJ episode_NN ._SENT There_EX are_VBP no_RB documented_VBN adverse_JJ effects_NNS of_IN general_JJ intensive_JJ care_NN on_IN cardiac_JJ function_NN or_CC on_IN potential_JJ symptomatic_JJ problems_NNS in_IN the_DT post-ICU_NP period_NN but_CC data_NNS are_VBP very_RB scarce_JJ ._SENT Postural_JJ hypotension_NN ,_, possibly_RB due_JJ to_TO a_DT residual_JJ autonomic_JJ neuropathy_NN ,_, can_MD be_VB problematic_JJ ;_: the_DT resulting_VBG dizziness_NN decreases_NNS mobility_NN and_CC independence_NN ._SENT Other_JJ physical_JJ problems_NNS |_SYM Reduced_JJ mobility_NN in_IN survivors_NNS of_IN intensive_JJ care_NN is_VBZ multifactor-ial_JJ :_: there_EX is_VBZ reduction_NN in_IN muscle_NN mass_NN ,_, muscle_NN weakness_NN ,_, joint_JJ stiffness_NN ,_, and_CC poor_JJ balance_NN ._SENT These_DT problems_NNS are_VBP generally_RB recognized_VBN and_CC the_DT appropriate_JJ physiotherapy_NN provided_VBD ._SENT Less_RBR obvious_JJ physical_JJ problems_NNS such_JJ as_IN swallowing_VBG difficulties_NNS may_MD go_VB unnoticed_JJ ._SENT Weakness_NN and_CC lack_NN of_IN coordination_NN of_IN the_DT pharyngeal_JJ musculature_NN can_MD initially_RB be_VB significant_JJ ,_, requiring_VBG persistent_JJ effort_NN by_IN the_DT patient_NN to_TO retrain_NN the_DT muscles_NNS ._SENT The_DT presence_NN of_IN a_DT tracheostomy_NN physically_RB impedes_VBZ swallowing_VBG ._SENT A_DT late_JJ complication_NN of_IN percutaneous_JJ tracheostomy_NN ,_, tethering_VBG of_IN the_DT skin_NN to_TO the_DT trachea_NN ,_, can_MD cause_VB a_DT distressing_JJ sensation_NN when_WRB swallowing_VBG and_CC may_MD need_VB surgical_JJ intervention_NN ._SENT There_EX are_VBP few_JJ long-term_JJ follow-up_NN studies_NNS of_IN percutaneous_JJ tracheostomy_NN ._SENT Those_DT available_JJ suggest_VBP a_DT favourable_JJ outcome_NN ,_, with_IN a_DT very_RB small_JJ incidence_NN of_IN significant_JJ complications_NNS ._SENT The_DT results_NNS of_IN long-term_JJ follow-up_NN studies_NNS are_VBP awaited_VBN ._SENT Interestingly_RB ,_, in_IN a_DT comment_NN relating_VBG to_TO his_PP$ experience_NN of_IN patients_NNS attending_VBG his_PP$ follow-up_NN clinic_NN ,_, Griffiths_NP suggests_VBZ that_IN significant_JJ tracheal_JJ stenosis_NN is_VBZ more_RBR commonly_RB associated_VBN with_IN repeated_JJ intubations_NNS ._SENT Sexual_JJ dysfunction_NN |_SYM Withdrawal_JJ from_IN sexual_JJ intimacy_NN can_MD have_VB detrimental_JJ effects_NNS on_IN relationships_NNS and_CC an_DT individual_NN 's_POS sense_NN of_IN well-being_NN ._SENT Quinlan_NP et_FW al._FW ,_, reporting_VBG on_IN the_DT follow-up_NN of_IN 62_CD patients_NNS ,_, found_VBD that_IN 26_CD %_NN reported_VBD sexual_JJ dysfunction_NN at_IN 2_CD months_NNS ,_, 19_CD %_NN at_IN 6_CD months_NNS ,_, and_CC 16_CD %_NN at_IN 1_CD year_NN ._SENT The_DT reasons_NNS given_VBN by_IN patients_NNS for_IN their_PP$ poor_JJ sex_NN life_NN in_IN that_DT study_NN and_CC a_DT subsequent_JJ study_NN were_VBD having_VBG no_DT desire_NN ,_, suffering_VBG impotence_NN despite_IN desire_NN ,_, shortness_NN of_IN breath_NN ,_, surgical_JJ disfigurement_NN ,_, and_CC concern_NN that_IN sex_NN might_MD precipitate_VB a_DT relapse_NN of_IN illness_NN ._SENT The_DT ICU_NP is_VBZ a_DT stressful_JJ and_CC noisy_JJ environment_NN with_IN little_JJ differentiation_NN between_IN night_NN and_CC day_NN ._SENT Patients_NNS are_VBP often_RB sedated_VBN with_IN psychoactive_JJ drugs_NNS during_IN at_IN least_JJS part_NN of_IN their_PP$ stay_NN ,_, the_DT long-term_JJ effects_NNS of_IN which_WDT are_VBP uncertain_JJ ._SENT Approximately_RB one-third_JJ of_IN the_DT patients_NNS attending_VBG our_PP$ own_JJ follow-up_NN clinic_NN complains_VBZ of_IN impaired_JJ memory_NN ,_, poor_JJ concentration_NN ,_, and/or_CC mental_JJ slowing_VBG 3_CD months_NNS after_IN ICU_NP discharge_NN (_( unpublished_JJ observation_NN )_) ._SENT How_WRB these_DT symptoms_NNS relate_VBP to_TO ICU_NP stay_NN is_VBZ currently_RB uncertain_JJ ._SENT Table_NP 2_CD |_SYM Common_JJ psychosocial_JJ problems_NNS following_VBG a_DT period_NN in_IN the_DT intensive_JJ care_NN unit_NN Delirium_NP |_SYM The_DT true_JJ incidence_NN of_IN delirium_NN in_IN the_DT ICU_NP is_VBZ unknown_JJ ._SENT Various_JJ terms_NNS have_VBP been_VBN used_VBN in_IN the_DT literature_NN to_TO describe_VB this_DT condition_NN ,_, including_VBG '_POS intensive_JJ care_NN syndrome_NN '_'' and_CC ICU_NP psychosis_NN ._SENT The_DT lack_NN of_IN an_DT evaluative_JJ tool_NN that_WDT could_MD be_VB used_VBN by_IN ICU_NP staff_NN to_TO diagnose_VB the_DT condition_NN in_IN patients_NNS who_WP are_VBP unable_JJ to_TO communicate_VB has_VBZ hampered_VBN the_DT collection_NN of_IN useful_JJ data_NNS ._SENT Estimates_NNS reported_VBD in_IN the_DT literature_NN suggest_VBP that_IN the_DT incidence_NN of_IN delirium_NN within_IN surgical_JJ intensive_JJ care_NN patients_NNS is_VBZ 40_CD %_NN ;_: the_DT incidence_NN may_MD be_VB as_RB high_JJ as_IN 60_CD %_NN in_IN older_JJR patients_NNS ._SENT Our_PP$ knowledge_NN of_IN the_DT long-term_JJ effects_NNS of_IN delirium_NN is_VBZ extremely_RB limited_VBN ._SENT The_DT diagnosis_NN of_IN delirium_NN ,_, in_IN all_DT but_CC the_DT most_RBS obvious_JJ cases_NNS ,_, may_MD not_RB be_VB straightforward_JJ ;_: apparent_JJ quiet_JJ withdrawal_NN may_MD be_VB a_DT manifestation_NN as_IN much_RB as_RB agitated_VBN confusion_NN ._SENT Ely_NP and_CC colleagues_NNS have_VBP recently_RB developed_VBN and_CC validated_VBN a_DT tool_NN for_IN the_DT bedside_NN assessment_NN of_IN delirium_NN in_IN ICU_NP patients_NNS ,_, which_WDT should_MD prove_VB valuable_JJ in_IN future_JJ long-term_JJ studies_NNS ._SENT Delirium_NN is_VBZ accompanied_VBN with_IN profound_JJ amnesia_NN of_IN events_NNS occurring_VBG during_IN and_CC preceding_VBG the_DT confusional_JJ state_NN ._SENT The_DT amnesia_NN results_NNS in_IN patients_NNS '_POS memories_NNS of_IN their_PP$ stay_NN in_IN the_DT ICU_NN being_VBG fragmented_VBN and_CC frequently_RB distorted_VBN ._SENT Slow_JJ wave_NN sleep_NN is_VBZ reduced_VBN in_IN patients_NNS in_IN the_DT ICU_NP ,_, which_WDT is_VBZ known_VBN to_TO be_VB important_JJ for_IN the_DT integration_NN of_IN factual_JJ memories_NNS ._SENT Patients_NNS may_MD enter_VB a_DT hypnagogic_JJ state_NN during_IN treatment_NN in_IN the_DT ICU_NP ,_, in_IN which_WDT control_NN of_IN the_DT boundary_NN between_IN internally_RB generated_VBN fantasy_NN and_CC the_DT experience_NN and_CC recognition_NN of_IN external_JJ reality_NN is_VBZ impaired_VBN ._SENT This_DT state_NN between_IN sleep_NN and_CC wakeful-ness_NN predisposes_VBZ to_TO hallucinations_NNS and_CC creates_VBZ a_DT mental_JJ environment_NN favouring_VBG the_DT development_NN of_IN paranoid_JJ delusions_NNS ._SENT During_IN the_DT immediate_JJ post-ICU_NN period_NN ,_, the_DT patient_NN begins_VBZ to_TO become_VB aware_JJ of_IN the_DT physical_JJ changes_NNS to_TO their_PP$ body_NN with_IN little_JJ conscious_JJ awareness_NN of_IN what_WP has_VBZ brought_VBN them_PP to_TO this_DT state_NN ._SENT They_PP may_MD have_VB only_RB vague_JJ memories_NNS of_IN pain_NN and_CC uncomfortable_JJ procedures_NNS ._SENT Nightmares_NNS ,_, dreams_NNS and_CC hallucinations_NNS have_VBP all_RB been_VBN described_VBN during_IN recovery_NN ._SENT The_DT recall_NN of_IN delusional_JJ memories_NNS may_MD predominate_VB and_CC there_EX is_VBZ some_DT evidence_NN that_IN delusional_JJ memories_NNS ,_, without_IN factual_JJ recall_NN ,_, are_VBP highly_RB associated_VBN with_IN the_DT early_JJ development_NN of_IN stress_NN disorders_NNS in_IN ICU_NP patients_NNS ._SENT The_DT lack_NN of_IN memory_NN of_IN the_DT illness_NN producing_VBG physical_JJ weakness_NN appears_VBZ to_TO be_VB a_DT cause_NN of_IN subsequent_JJ frustration_NN ._SENT Affective_JJ disorders_NNS |_SYM Symptoms_NP of_IN anxiety_NN and_CC depression_NN are_VBP common_JJ ._SENT In_IN a_DT postal_JJ questionnaire_NN study_NN of_IN general_JJ intensive_JJ care_NN survivors_NNS ,_, Scragg_NP et_FW al._FW reported_VBD that_IN 38_CD out_RP of_IN 80_CD respondents_NNS (_( 47_CD %_NN )_) reported_VBD clinically_RB significant_JJ anxiety_NN and_CC depression_NN as_IN measured_VBN by_IN the_DT Hospital_NP Anxiety_NP and_CC Depression_NP scale_NN ._SENT Nelson_NP et_FW al._FW investigated_VBN depression_NN in_IN survivors_NNS (_( median_JJ period_NN ,_, 15_CD months_NNS )_) after_IN intensive_JJ care_NN for_IN acute_JJ lung_NN injury_NN ._SENT Sixty-nine_NN percent_NN of_IN patients_NNS without_IN a_DT pre-existing_VBG history_NN of_IN depression_NN had_VBD clinically_RB relevant_JJ depressive_JJ symptoms_NNS ,_, which_WDT correlated_VBD with_IN the_DT days_NNS of_IN sedation_NN and_CC the_DT use_NN of_IN neuromuscular_JJ blockade_NN ._SENT In_IN a_DT study_NN of_IN a_DT more_RBR varied_JJ case_NN mix_NN of_IN ICU_NP patients_NNS at_IN 3_CD month_NN follow-up_NN ,_, Eddleston_NP et_FW al._FW found_VBD a_DT lower_JJR prevalence_NN of_IN psychological_JJ distress_NN (_( Hospital_NP Anxiety_NP and_CC Depression_NP scale_NN score_NN >8_NN )_) :_: anxiety_NN ,_, 11.9_CD %_NN ;_: depression_NN ,_, 9.8_CD %_NN ._SENT Jones_NP et_FW al._FW reported_VBD clinically_RB significant_JJ Hospital_NP Anxiety_NP and_CC Depression_NP scale_NN scores_NNS in_IN ICU_NP patients_NNS ;_: notably_RB ,_, those_DT who_WP could_MD not_RB recall_VB any_DT factual_JJ memory_NN of_IN events_NNS during_IN their_PP$ ICU_NP stay_NN but_CC who_WP retained_VBD delusional_JJ thoughts_NNS ._SENT Stress_NN disorders_NNS |_SYM Post-traumatic_JJ stress_NN disorder_NN (_( PTSD_NN )_) is_VBZ a_DT condition_NN that_WDT occurs_VBZ in_IN individuals_NNS who_WP have_VBP experienced_VBN a_DT traumatic_JJ event_NN ._SENT In_IN this_DT condition_NN ,_, a_DT '_'' traumatic_JJ '_'' event_NN is_VBZ characterized_VBN by_IN its_PP$ capacity_NN to_TO provoke_VB fear_NN ,_, helplessness_NN ,_, or_CC horror_NN in_IN response_NN to_TO the_DT threat_NN of_IN injury_NN or_CC death_NN ._SENT Symptoms_NNS include_VBP distressing_JJ '_'' flash_NN backs_NNS '_'' (_( re-experiencing_VBG of_IN the_DT event_NN )_) ,_, avoidance_NN of_IN situations_NNS reminding_VBG the_DT individual_NN of_IN the_DT event_NN ,_, increased_VBN arousal_NN ,_, and_CC psychological_JJ numbing_VBG ._SENT The_DT incidence_NN of_IN PTSD_NN in_IN patients_NNS following_VBG an_DT ICU_NP stay_NN varies_VBZ ;_: patients_NNS who_WP have_VBP survived_VBN ARDS_NNS and_CC younger_JJR patients_NNS appearing_VBG to_TO be_VB particularly_RB vulnerable_JJ ._SENT Schelling_NP and_CC colleagues_NNS found_VBD that_IN memories_NNS of_IN adverse_JJ experiences_NNS correlated_VBN with_IN subsequent_JJ PTSD_JJ symptoms_NNS ,_, and_CC were_VBD also_RB related_VBN to_TO poor_JJ general_JJ quality_NN of_IN life_NN scores_NNS ._SENT By_IN contrast_NN ,_, Jones_NP et_FW al._FW found_VBD that_IN factual_JJ memories_NNS seemed_VBD in_IN some_DT way_NN protective_NN and_CC that_IN delusional_JJ memories_NNS without_IN factual_JJ recall_NN was_VBD a_DT situation_NN more_JJR associated_VBN with_IN early_JJ stress_NN symptoms_NNS at_IN 8_CD weeks_NNS ._SENT The_DT Schelling_NP et_FW al._FW study_NN did_VBD not_RB attempt_VB to_TO differentiate_VB factual_JJ from_IN delusional_JJ memories_NNS and_CC was_VBD undertaken_VBN years_NNS after_IN discharge_NN ._SENT These_DT two_CD important_JJ studies_NNS are_VBP thus_RB complementary_JJ rather_RB than_IN contradictory_NN ._SENT In_IN Scragg_NP et_FW al._FW 's_POS postal_JJ study_NN ,_, 30_CD survivors_NNS (_( 38_CD %_NN )_) reported_VBD symptoms_NNS of_IN PTSD_NN ,_, as_RB assessed_VBN by_IN the_DT Trauma_NP Symptoms_NP Checklist_NP 33_CD and_CC the_DT Impact_NN of_IN Events_NP Scale_NP ._SENT Using_VBG the_DT Experience_NN after_IN Treatment_NP in_IN Intensive_NP Care_NP 7_CD Item_NP Scale_NP ,_, an_DT additional_JJ questionnaire_NN designed_VBN specifically_RB for_IN their_PP$ study_NN ,_, Scragg_NP et_FW al._FW were_VBD able_JJ to_TO show_VB that_DT intensive_JJ care_NN treatment_NN contributed_VBD to_TO the_DT causation_NN of_IN post-traumatic_JJ stress_NN ._SENT Patients_NNS may_MD experience_VB symptoms_NNS of_IN an_DT acute_JJ stress_NN disorder_NN during_IN the_DT early_JJ phase_NN of_IN their_PP$ recovery_NN ._SENT This_DT condition_NN is_VBZ a_DT recent_JJ diagnostic_JJ category_NN ,_, being_VBG defined_VBN for_IN the_DT first_JJ time_NN in_IN the_DT fourth_JJ edition_NN of_IN the_DT Diagnostic_NP and_CC Statistical_NP Manual_NP of_IN Mental_NP Disorders_NP in_IN 1999_CD ._SENT Acute_JJ stress_NN disorder_NN is_VBZ characterized_VBN by_IN the_DT early_JJ development_NN of_IN symptoms_NNS similar_JJ to_TO PTSD_NN ,_, with_IN the_DT inclusion_NN of_IN dissociative_JJ symptoms_NNS such_JJ as_IN detachment_NN ,_, depersonalization_NN ,_, derealization_NN ,_, and_CC dissociative_JJ amnesia_NN ._SENT Although_IN the_DT description_NN of_IN this_DT condition_NN as_IN a_DT distinct_JJ disorder_NN from_IN severe_JJ acute_JJ PTSD_NN has_VBZ been_VBN questioned_VBN ,_, its_PP$ recognition_NN allows_VBZ early_JJ psychological_JJ intervention_NN to_TO facilitate_VB a_DT patient_NN 's_POS resolution_NN of_IN the_DT traumatic_JJ experience_NN ._SENT Disorders_NNS of_IN cognitive_JJ function_NN |_SYM In_IN a_DT landmark_JJ study_NN of_IN ARDS_JJ survivors_NNS ,_, Hopkins_NP and_CC colleagues_NNS reported_VBD that_IN 100_CD %_NN of_IN survivors_NNS experienced_VBD cognitive_JJ impairment_NN at_IN hospital_NN discharge_NN ,_, including_VBG problems_NNS of_IN memory_NN ,_, attention_NN and_CC concentration_NN ._SENT Although_IN they_PP demonstrated_VBD improvements_NNS at_IN 1_CD year_NN follow-up_NN ,_, 30_CD %_NN of_IN patients_NNS were_VBD still_RB globally_RB impaired_VBN and_CC 78_CD %_NN were_VBD impaired_VBN in_IN one_CD or_CC all_DT of_IN the_DT domains_NNS assessed_VBD ._SENT Hopkins_NP et_FW al._FW associated_VBN the_DT deficits_NNS with_IN hypoxaemic_JJ episodes_NNS periods_NNS in_IN the_DT ICU_NP ._SENT This_DT added_VBD to_TO earlier_JJR work_NN ,_, which_WDT had_VBD demonstrated_VBN the_DT relation_NN between_IN hypoxic_JJ brain_NN injury_NN ,_, hippocampal_JJ atrophy_NN ,_, and_CC memory_NN deficit_NN ._SENT Rothenhausler_NP et_FW al._FW investigated_VBN cognitive_JJ performance_NN in_IN ARDS_JJ patients_NNS at_IN a_DT median_JJ time_NN of_IN 6_CD years_NNS after_IN ICU_NP discharge_NN ._SENT These_DT investigators_NNS found_VBD that_IN 75_CD %_NN of_IN ARDS_JJ survivors_NNS did_VBD not_RB display_VB signs_NNS of_IN cognitive_JJ impairment_NN ._SENT Of_IN the_DT remaining_VBG 25_CD %_NN ,_, the_DT impairment_NN was_VBD either_DT subthreshold_NN or_CC mild_JJ in_IN the_DT vast_JJ majority_NN ._SENT The_DT residual_JJ mild_JJ cognitive_JJ impairments_NNS demonstrated_VBN were_VBD found_VBN in_IN subtests_NNS relating_VBG to_TO attention_NN ._SENT Although_IN the_DT impairments_NNS were_VBD described_VBN as_IN mild_JJ ,_, all_DT patients_NNS with_IN cognitive_JJ dysfunction_NN were_VBD classified_VBN as_IN disabled_JJ ,_, compared_VBN with_IN 22.9_CD %_NN of_IN those_DT without_IN cognitive_JJ impairment_NN ._SENT The_DT investigators_NNS also_RB found_VBD that_IN 58.7_CD %_NN of_IN survivors_NNS returned_VBN to_TO work_VB ._SENT These_DT figures_NNS ,_, similar_JJ to_TO those_DT published_VBN by_IN McHugh_NP et_FW al._FW (_( 56_CD %_NN )_) and_CC Schelling_NP et_FW al._FW (_( 61.3_CD %_NN )_) ,_, indicate_VBP a_DT significant_JJ critical_JJ care_NN achievement_NN ._SENT The_DT corollary_NN of_IN this_DT ,_, however_RB ,_, is_VBZ that_IN there_EX remained_VBD a_DT significant_JJ proportion_NN of_IN survivors_NNS whose_WP$ employment_NN status_NN was_VBD significantly_RB impaired_VBN ,_, implying_VBG a_DT negative_JJ social_JJ outcome_NN ._SENT Social_JJ and_CC family_NN consequences_NNS |_SYM During_IN the_DT patient_NN 's_POS stay_NN in_IN intensive_JJ care_NN the_DT family_NN members_NNS ,_, and_CC especially_RB the_DT spouse_NN ,_, have_VBP been_VBN shown_VBN to_TO exhibit_VB significant_JJ degrees_NNS of_IN anxiety_NN and_CC depression_NN ._SENT After_IN the_DT patient_NN has_VBZ been_VBN discharged_VBN from_IN hospital_NN this_DT anxiety_NN and_CC depression_NN may_MD manifest_VB itself_PP in_IN overprotective_JJ behaviour_NN that_IN ,_, coupled_VBN with_IN unrealistic_JJ expectations_NNS that_IN the_DT patient_NN may_MD have_VB of_IN their_PP$ capabilities_NNS ,_, leads_VBZ to_TO frustration_NN and_CC conflict_NN ._SENT Survivors_NNS may_MD experience_VB guilt_NN as_IN they_PP become_VBP aware_JJ of_IN the_DT strain_NN placed_VBN on_IN their_PP$ family_NN ,_, which_WDT adds_VBZ to_TO their_PP$ psychological_JJ burden_NN predisposing_VBG them_PP to_TO affective_JJ disorders_NNS ._SENT The_DT Study_NN to_TO Understand_NP Prognoses_NNS and_CC Preferences_NNS for_IN Outcomes_NP and_CC Risks_NP of_IN Treatment_NP investigators_NNS collected_VBD data_NNS to_TO assess_VB the_DT impact_NN of_IN critical_JJ illness_NN on_IN the_DT family_NN ._SENT They_PP reported_VBD that_IN 34_CD %_NN of_IN patients_NNS required_VBN considerable_JJ care-giving_JJ assistance_NN ._SENT A_DT family_NN member_NN needed_VBN to_TO give_VB up_RP work_NN or_CC make_VB major_JJ life_NN changes_NNS to_TO provide_VB care_NN for_IN their_PP$ relative_NN in_IN 20_CD %_NN of_IN the_DT total_NN ._SENT It_PP is_VBZ possible_JJ that_IN multidisciplinary_JJ intensive_JJ care_NN follow-up_NN needs_VBZ to_TO address_VB the_DT needs_NNS of_IN the_DT family_NN during_IN the_DT rehabilitation_NN phase_NN ._SENT Quality_NN of_IN life_NN |_SYM People_NNS with_IN the_DT same_JJ health_NN status_NN may_MD not_RB necessarily_RB enjoy_VB the_DT same_JJ quality_NN of_IN life_NN ._SENT Health_NN and_CC well-being_NN are_VBP multidimensional_JJ ,_, and_CC they_PP include_VBP aspects_NNS such_JJ as_IN individuals_NNS '_POS subjective_JJ values_NNS and_CC preferences_NNS that_WDT make_VBP the_DT direct_JJ measurement_NN of_IN quality_NN of_IN life_NN difficult_JJ ._SENT Item_NN measurement_NN theory_NN proposes_VBZ that_IN true_JJ quality_NN of_IN life_NN can_MD be_VB measured_VBN indirectly_RB via_IN a_DT series_NN of_IN questions_NNS (_( items_NNS )_) ,_, each_DT of_IN which_WDT is_VBZ a_DT measure_NN of_IN the_DT same_JJ concept_NN or_CC construct_VB ._SENT The_DT answers_NNS are_VBP assigned_VBN numerical_JJ scores_NNS that_WDT may_MD be_VB combined_VBN to_TO provide_VB '_'' scale_NN '_POS scores_NNS (_( e.g._FW physical_JJ functioning_NN ,_, symptom_NN ,_, distress_NN ,_, or_CC well-being_NN scales_NNS )_) ._SENT These_DT scores_NNS may_MD then_RB be_VB further_RBR combined_JJ to_TO give_VB '_'' domain_NN '_POS scores_NNS (_( e.g._FW physical_JJ ,_, psychological_JJ ,_, work_NN performance_NN )_) ._SENT HRQL_NP measures_VBZ potentially_RB provide_VB a_DT holistic_JJ measure_NN of_IN the_DT impact_NN of_IN critical_JJ illness_NN on_IN the_DT patient_NN ,_, a_DT measure_NN of_IN the_DT contribution_NN of_IN disease-specific_JJ changes_NNS in_IN health_NN to_TO overall_JJ patient_JJ well-being_NN ,_, and_CC a_DT means_VBZ to_TO evaluate_VB the_DT health_NN economic_JJ impact_NN of_IN intensive_JJ care_NN medicine_NN (_( e.g._FW the_DT Quality_NP Adjusted_NP Life_NP Year_NN estimates_NNS )_) ._SENT Kutsogiannis_NP and_CC Noseworthy_NP have_VBP comprehensively_RB reviewed_VBN the_DT available_JJ HRQL_NP instruments_NNS ,_, highlighting_VBG the_DT complexity_NN of_IN creating_VBG and_CC using_VBG HRQL_NP instruments_NNS appropriately_RB ._SENT By_IN way_NN of_IN a_DT caution_NN ,_, Ridley_NP has_VBZ recommended_VBN that_IN the_DT psychometric_JJ properties_NNS of_IN questionnaires_NNS ,_, which_WDT may_MD not_RB have_VB been_VBN designed_VBN specifically_RB for_IN critically_RB ill_JJ patients_NNS ,_, should_MD be_VB tested_VBN and_CC validated_VBN in_IN critically_RB ill_JJ patients_NNS before_IN the_DT results_NNS are_VBP presented_VBN ._SENT Mata_NP et_FW al._FW have_VBP published_VBN the_DT results_NNS of_IN a_DT quality-of-life_NN questionnaire-based_JJ study_NN ._SENT The_DT questionnaire_NN was_VBD completed_VBN by_IN patients_NNS or_CC a_DT proxy_NN at_IN the_DT time_NN of_IN admission_NN to_TO the_DT ICU_NP ,_, and_CC was_VBD compared_VBN with_IN the_DT results_NNS of_IN the_DT same_JJ questionnaire_NN completed_VBN by_IN the_DT survivors_NNS 12_CD months_NNS later_RBR (_( 444_CD of_IN the_DT initial_JJ 606_CD patients_NNS )_) ._SENT The_DT quality_NN of_IN life_NN was_VBD reduced_VBN in_IN 50_CD %_NN of_IN survivors_NNS ,_, remained_VBD the_DT same_JJ in_IN 23_CD %_NN and_CC improved_VBN in_IN 27_CD %_NN ._SENT A_DT decreased_VBN quality_NN of_IN life_NN was_VBD most_RBS evident_JJ in_IN those_DT older_JJR than_IN 75_CD years_NNS of_IN age_NN ._SENT The_DT pre-ICU_NN quality_NN of_IN life_NN and_CC age_NN were_VBD the_DT factors_NNS with_IN the_DT greatest_JJS influence_NN on_IN post-ICU_NN quality_NN of_IN life_NN ._SENT This_DT original_JJ seven-item_NN Quality_NP of_IN Life_NP --_: Spanish_JJ questionnaire_NN has_VBZ since_RB been_VBN modified_VBN to_TO create_VB a_DT 15-item_JJ quality-of-life_NN questionnaire_NN specifically_RB for_IN critically_RB ill_JJ patients_NNS ._SENT Konopad_NP et_FW al._FW used_VBN Spitzer_NP 's_POS Quality_NP of_IN Life_NP Index_NP ,_, which_WDT examines_VBZ the_DT activity_NN level_NN ,_, the_DT activities_NNS of_IN daily_JJ living_NN ,_, health_NN ,_, support_NN ,_, and_CC outlook_NN ._SENT Of_IN the_DT original_JJ group_NN of_IN 504_CD general_JJ ICU_NP patients_NNS who_WP completed_VBD a_DT baseline_JJ questionnaire_NN at_IN ICU_NP admission_NN ,_, 293_CD completed_VBD a_DT 12-month_JJ follow-up_NN questionnaire_NN ._SENT A_DT significant_JJ decrease_NN in_IN the_DT level_NN of_IN activity_NN score_NN and_CC the_DT activities_NNS of_IN daily_JJ living_NN score_NN occurred_VBD at_IN 12_CD months_NNS ,_, and_CC these_DT scores_NNS were_VBD more_RBR significant_JJ in_IN the_DT older_JJR age_NN group_NN ._SENT Using_VBG their_PP$ own_JJ quality-of-life_NN questionnaire_NN administered_VBN to_TO 238_CD patients_NN 16_CD months_NNS after_IN discharge_NN ,_, Brooks_NP et_FW al._FW found_VBD that_IN survivors_NNS have_VBP more_JJR health_NN problems_NNS ,_, are_VBP more_RBR anxiously_RB depressed_VBN ,_, are_VBP more_RBR dependent_JJ on_IN others_NNS ,_, and_CC engage_VB in_IN less_JJR sexual_JJ activity_NN than_IN a_DT random_JJ community_NN sample_NN ._SENT A_DT number_NN of_IN investigators_NNS have_VBP used_VBN the_DT SF-36_NP instrument_NN ,_, which_WDT consists_VBZ of_IN 36_CD questions_NNS covering_VBG eight_CD domains_NNS and_CC has_VBZ been_VBN validated_VBN in_IN the_DT intensive_JJ care_NN setting_NN ._SENT Compared_VBN with_IN age-matched_JJ and_CC gender-matched_JJ controls_NNS ,_, Schelling_NP et_FW al._FW report_NN that_IN survivors_NNS of_IN ARDS_NN ,_, at_IN a_DT median_JJ follow-up_NN interval_NN of_IN 4_CD years_NNS ,_, experienced_VBD a_DT 25_CD %_NN reduction_NN in_IN physical_JJ function_NN and_CC described_VBD their_PP$ general_JJ health_NN as_IN 15_CD %_NN lower_JJR ._SENT Mental_JJ health_NN dimensions_NNS of_IN the_DT SF-36_NP were_VBD also_RB significantly_RB impaired_VBN ,_, although_IN to_TO a_DT lesser_JJR degree_NN (_( 4_CD %_NN reduction_NN in_IN mental_JJ health_NN ,_, 15_CD %_NN reduction_NN in_IN vitality_NN ,_, 10_CD %_NN reduction_NN in_IN social_JJ function_NN )_) ._SENT In_IN that_DT and_CC a_DT more_RBR recent_JJ study_NN by_IN Eddleston_NP et_FW al._FW ,_, which_WDT examined_VBD a_DT broader_JJR ICU_NP case_NN mix_NN ,_, the_DT SF-36_NP scores_NNS of_IN younger_JJR survivors_NNS were_VBD found_VBN to_TO be_VB worse_JJR ;_: particularly_RB in_IN physical_JJ and_CC emotional_JJ role_NN limitation_NN ,_, and_CC in_IN social_JJ functioning_NN ._SENT A_DT report_NN by_IN Flaatten_NP and_CC Kvale_NP on_IN survivors_NNS 12_CD years_NNS after_IN ICU_NP treatment_NN described_VBD a_DT similar_JJ global_JJ reduction_NN in_IN SF-36_NP scale_NN scores_NNS ,_, with_IN reductions_NNS in_IN six_CD of_IN the_DT eight_CD scale_NN scores_NNS ._SENT The_DT pattern_NN and_CC scores_NNS of_IN the_DT SF-36_NP in_IN these_DT studies_NNS were_VBD similar_JJ to_TO those_DT described_VBN by_IN Ridley_NP et_FW al._FW ,_, who_WP were_VBD also_RB able_JJ to_TO show_VB that_IN the_DT quality_NN of_IN life_NN of_IN patients_NNS admitted_VBN to_TO their_PP$ ICU_NP was_VBD not_RB the_DT same_JJ as_IN the_DT normal_JJ population_NN ._SENT Patients_NNS who_WP enjoyed_VBD a_DT normal_JJ quality_NN of_IN life_NN before_IN admission_NN suffered_VBD significant_JJ decreases_NNS following_VBG their_PP$ illness_NN ._SENT Those_DT with_IN pre-existing_VBG morbidity_NN showed_VBD some_DT improvement_NN in_IN their_PP$ quality_NN of_IN life_NN 6_CD months_NNS after_IN intensive_JJ care_NN admission_NN ,_, principally_RB by_IN improvements_NNS in_IN mental_JJ health_NN ,_, vitality_NN and_CC social_JJ functioning_NN ._SENT What_WP have_VBP ICU_NP follow-up_NN studies_NNS shown_VBN us_PP overall_JJ ?_SENT Survival_NN curves_NNS do_VBP not_RB run_VB parallel_RB to_TO those_DT of_IN the_DT average_JJ population_NN until_IN 2_CD --_: 3_CD years_NNS post-ICU_NN discharge_NN ._SENT '_'' Survival_NP '_POS ,_, however_RB ,_, is_VBZ a_DT poor_JJ metric_NN for_IN describing_VBG the_DT impact_NN of_IN critical_JJ illness_NN ._SENT We_PP as_RB yet_RB have_VB an_DT inadequate_JJ understanding_NN of_IN how_WRB events_NNS in_IN the_DT ICU_NP impact_NN on_IN recovery_NN ._SENT The_DT physical_JJ and_CC psychological_JJ consequences_NNS can_MD be_VB significant_JJ and_CC unanticipated_JJ ._SENT The_DT neuropsychological_JJ picture_NN is_VBZ beginning_VBG to_TO emerge_VB ;_: a_DT subject_NN that_WDT warrants_VBZ much_RB further_JJR study_NN ._SENT The_DT burden_NN carried_VBN by_IN families_NNS or_CC future_JJ caregivers_NNS is_VBZ potentially_RB great_JJ and_CC ,_, as_IN yet_RB ,_, we_PP have_VBP little_JJ data_NNS concerning_VBG the_DT fiscal_JJ impact_NN of_IN ICU_NP survival_NN ._SENT Increasing_VBG knowledge_NN in_IN these_DT areas_NNS will_MD provide_VB us_PP with_IN the_DT potential_NN to_TO modify_VB our_PP$ approach_NN inside_IN the_DT ICU_NP to_TO improve_VB patient-centred_JJ outcomes_NNS in_IN the_DT long_JJ term_NN ._SENT None_NN declared_VBD ARDS_NNS =_SYM acute_JJ respiratory_JJ distress_NN syndrome_NN ;_: HRQL_NP =_SYM health-related_JJ quality_NN of_IN life_NN ;_: ICU_NP =_SYM intensive_JJ care_NN unit_NN ;_: PTSD_NNS =_SYM post-traumatic_JJ stress_NN disorder_NN ;_: SF-36_NP =_SYM Medical_NP Outcomes_NP Study_NP Short_NP Form_NP (_( SF-36_NP )_) instrument_NN ._SENT Figure_NP 1_CD |_SYM Factors_NNS impacting_VBG on_IN recovery_NN from_IN the_DT intensive_JJ care_NN unit_NN ._SENT Factors_NNS impacting_VBG on_IN recovery_NN from_IN the_DT intensive_JJ care_NN unit_NN ._SENT 